Kyntra Bio Inc (KYNB) vs Seres Therapeutics, Inc. (MCRB)
- Kyntra Bio Inc KYNB 3.44 −4.18%
- Seres Therapeutics, Inc. MCRB 1.40 −0.71%
Kyntra Bio Inc and Seres Therapeutics, Inc. are both Biotechnology companies. Kyntra Bio Inc and Seres Therapeutics, Inc. are of similar size ($14.5M and $14.4M). Seres Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc grew revenue faster over the last twelve months: −37.2% against −98.3%. Kyntra Bio Inc has the higher net margin (3,967.8% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 16 metrics below, Kyntra Bio Inc leads on 13 and Seres Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | KYNB | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 6.28% | 100.00% | 67.24% |
| Operating margin | (1,089.78%) | (3,656.89%) | 0.00% |
| Net margin | 3,967.77% | (2,209.55%) | 0.00% |
| Free cash flow margin | (824.19%) | (2,997.74%) | 0.00% |
| Return on equity | (157.83%) | (144.35%) | (50.28%) |
| Return on assets | 131.26% | (44.85%) | (45.89%) |
| Return on invested capital | 0.00% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack